SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-22-008344
Filing Date
2022-03-22
Accepted
2022-03-22 17:52:56
Documents
1
Period of Report
2022-03-21

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 12120
  Complete submission text file 0001062993-22-008344.txt   13502
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ZYMOGENETICS, INC. 1201 EASTLAKE AVENUE SEATTLE WA 98102
Business Address
CARTER BRUCE L A (Reporting) CIK: 0001225503 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 22760967